Serve You Rx delivers tailored solutions to help employers manage specialty drug costs, ensure transparency in PBM pricing, and navigate biosimilar formularies. Our programs focus on cost control, utilization management, and ensuring members receive the right medications at the right time.

Serve You Rx received the Validation Institute’s designation for contract transparency. The designation was awarded following independent review of the company’s pass-through contract by the Institute, a third-party organization focused on improving healthcare quality.

Our most recent pipeline report discloses a list of new medications that may influence your clients’ plans. By constantly monitoring the pipeline, you can ensure that you are providing the most clinically effective and cost-efficient options available.

We achieved a remarkable NPS of 89 over the last year for our implementations, showcasing our commitment to exceptional service by creating a smooth, customer-centered implementation experience, even in complex situations.  

Our client satisfaction (CSAT) metrics align with these positive NPS scores. With an overall rating of 4.83, our client feedback underscores our dedication to a smooth and flexible implementation experience. 

Through the process, we provide second-to-none service and help clients seamlessly onboard, supporting their unique health plan needs and ensuring a positive experience from the outset.

As your pharmacy benefits partner, we’re introducing two significant formulary enhancements for 2025 to help you deliver more value to your clients. The key updates address Wegovy coverage for cardiovascular care and Humira coverage strategy to maximize biosimilar benefits.

As an independently held PBM, we’ve long understood that divided loyalties can compromise service quality—a reality this client discovered firsthand. Despite attractive savings estimates, they encountered significant plan setup errors from day one, leading to member disruption and plan sponsor dissatisfaction. When solutions remained elusive months later, they returned to Serve You Rx, where client needs—not insurance company profits—drive our decisions. 

Below are significant compliance and pharmacy benefit updates that occurred during the third quarter of 2024. While many new regulations target the “Big 3” PBMs and their insurance company owners (known as BUCAHs), independent PBMs like Serve You Rx continue to put clients first. As a privately held PBM focused on flexibility and transparency, we remain committed to your goals rather than shareholder interests. These updates include new regulatory actions at both federal and state levels, court rulings, and ongoing legal challenges affecting pharmacy benefit managers and prescription drug pricing. 

As a pharmacist-founded company, we’ve built our service model around the principle that exceptional pharmacy expertise drives everything we do. It’s the people behind the prescriptions who make our pharmacy stand out. Our team members aren’t just specialists in pharmacy benefits; they’re Serve You Rx experts, deeply rooted in our culture of growth, continuous improvement, and unwavering commitment to service. 

Renewal discussions can sometimes feel complex and even overwhelming. That’s why we’ve worked hard to streamline and conversationalize our process so you can focus on what matters most—your clients. Our goal is to make renewals easier for you to review and communicate.  The plan renewal process follows a conversational path: we send you performance metrics…

Our CEO, Justin Jasniewski, recently appeared on a “Self Funding with Spencer” podcast episode, offering valuable insights into pharmacy benefit management and GLP-1s, PBM transparency, and gene therapies Self Funded with Spencer featuring Justin Jasniewski Episode Highlights In this informative episode, Justin discusses: The PBM Perspective on GLP-1s, PBM Transparency, and Gene Therapies Justin Jasniewski,…